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Background: Conjugated linoleic acids (CLA) are fatty acids that are found in the lipids from goat milk, and
appear to protect neurons from excitotoxicity.
Methods:We investigated in developing rats the effects of a maternal CLA-rich diet (containing 7% lipids from
goat milk) on body development and cerebral electrical activity of the progeny from dams receiving the CLA
diet during gestation (G), lactation (L) or both periods (G+L).
Results: Compared to a control group (C) receiving a diet with 7% soybean oil, body weight increased at 14, 21
and 28 days, but not at 35–45 days, in L and G+L groups (Pb0.05). No intergroup difference was found on
body and brain weights, body length, abdominal and thoracic circumferences, body mass index and abdominal
to thoracic circumference ratio at 35–45 days. In contrast, at this later age the CSD velocities of propagation
were signiﬁcantly higher (Pb0.05) in L as compared with the C and G group, and in the L+G, as compared
with the C, G and L groups, suggesting a long-lasting brain effect.
Conclusion: These data indicate that a maternal CLA-rich diet can differentially inﬂuence body weight increment
(short-term effect), and CSD propagation (long-term effect) in the progeny, and the lactation is themost critical
period for such diet actions.
General signiﬁcance: The facilitating effect of the lipids from goat milk on an excitability-related phenomenon in
the brain (CSD) can be of clinical relevance, since CSD has been associated to neurological disturbances like mi-
graine and epilepsy.© 2012 Elsevier B.V. All rights reserved.1. Introduction
Dietary lipids play an important role in the brain development. After
the adipose tissue, the brain is the organwith the highest concentration
of lipids [1]. Inmammals, the dietary essential fatty acids (EFA) received
by the pregnant and lactating mothers are extremely important for the
brain development of their progeny, since the organism is not capable
of synthesizing EFAs. Thus, the brain requirements of polyunsaturated
fatty acids (PUFA) must be supplied by the diet [2]. Dietary deviations
in maternal fatty acids intake throughout pregnancy may affect the
nature of fetal fatty acids, affecting postnatal development.
Polyunsaturated fatty acids are synthesized in mammals from two
precursors: α-linoleic acid (18:2n−6) and α-linolenic acid (18:3n−3),
with the participation of the enzymes known as desaturases and
elongases [3–6]. Strategies have been proposed to modify the maternal+55 81 21268473.
fpe.br (R.C.A.. Guedes).
l rights reserved.intake of certain essential fatty acids to warrant their availability to the
fetus, but an excess of certain fatty acids may impair the availability of
others, with undesirable consequences to the newborns [7]. One group
of isomers of the linoleic acid with double bonds in cis-, trans- or
mixed conﬁgurations, generically designated as “Conjugated linoleic
acids” (CLA) [8], has been shown to have positive health effects such as
attenuation of carcinogenesis and atherogenesis, and modulation of the
immune system, and diabetes [9]. CLA comprise a family of isomers of
linoleic acid (18:2n−6) that are formed by biohydrogenation in the
rumen of ruminants by the action of rumen bacteria [10,11]. The goat
milk is a good source of CLA. It is an alternative for infants and adults
sensitive or allergic to cow milk [12]. The content of CLA in goat milk
fat is inﬂuenced mainly by the diet composition. Large amounts of
linolenic and linoleic acid in the goat diet result in elevated content of
CLA in the milk [9,13].
Regarding the action of CLA on the central nervous system, it is
known that CLA crosses the blood–brain barrier and is incorporated
and metabolized in the brain [14]. The chronic dietary CLA intake
can reduce cerebral prostaglandin E2 in the peripheral and central
nervous system [15]. Besides that, CLA exerts antiangiogenic actions
Table 1
Fatty acid percent composition of the diets.
Fatty acid Control diet CLA diet
C4:0 – 0.95
C6:0 – 0.96
C8:0 – 0.99
C10:0 – 3.60
C12:0 – 2.10
C14:0 0.42 6.40
C15:0 – 0.63
C16:0 17.10 24.26
C16:1 – 0.34
C17:0 0.34 0.53
C18:0 5.93 20.94
C18:1(n9) 28.53 28.79
C18:2(n6) 42.56 5.97
C18:2(n6)CLA – 1.20
C18:3(n3) 1.89 0.63
C20:1 2.18 –
C22:0 0.53 –
n6/n3 22.52 11.38
Others 0.52 1.71
Total (%) 100 100
Values are means of triplicate measurements.
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tect cortical neurons from excitotoxicity [17].
The inﬂuence of the dietary lipids on neuronal excitability has also
been investigated using the electrophysiological phenomenon known
as cortical spreading depression (CSD) [18,19]. However, no data are
available yet on the excitability effects of CLA. This issue has been
addressed in the present study by recording the excitability-related
CSD phenomenon.
CSD is a fully reversible, excitability-related neural response ﬁrst
described as a slowly propagating wave of depression of spontaneous
neuronal activity produced by electrical, mechanical or chemical
stimulation of one point on brain tissue, from which it spreads con-
centrically to remote cortical regions [20]. CSD has already been dem-
onstrated in the central nervous system of several laboratory animals
[21] and also in the human brain [22]. The brain recovery process
from CSD is completed 5–10 min after being elicited, rendering
again the brain tissue prone to another CSD. Measuring CSD velocity
of propagation along the cortical tissue is a reasonable and easy way
of estimating the brain CSD susceptibility. During the initial phase of
CSD, the spontaneous brain electrical activity is depressed and this
EEG depression spreads slowly all over the brain cortical surface
[20]. This phenomenon is reversible and is characterized by particular
ionic, metabolic and hemodynamic changes [21]. CSD is dependent of
the neuron–glia interactions and can be affected by several conditions
including nutritional [23] and pharmacological [24] manipulations.
There are several reports showing that CSD seems to be involved in
various pathophysiological events with clinical importance for
humans including ischemia [25] migraine [26], and epilepsy [27].
Using CSD as a neurophysiologic parameter, in this study we inves-
tigated the impact of feeding pregnant and/or lactating rat dams with a
CLA-rich diet on the developmental (body weight and metric parame-
ters) and electrophysiological CSD effects on their male progeny. We
postulated that susceptibility of the brain to CSD could be altered in
the pups by the maternal dietary CLA treatment. Two questions were
addressed in the weaned progeny. First, how does administration of a
CLA-rich diet to pregnant and/or lactating dams affect body growth
and CSD propagation in the progeny? Second, in which of the treatment
periods would the CLA-rich diet have more of an impact in terms of
altering the susceptibility of the progeny brain to CSD?
2. Methods
2.1. Animals
Female Wistar rats (120–150 days of life; 300±50 g) were mated
in the proportion of two female to one male. Once the presence of
vaginal sperm plug was detected (considered gestational day 0), the
female was removed and housed in individual cages with free access
to food and water. The animals were kept in a roomwith temperature
of 22±1 °C, a 12/12 h light/dark cycle (light phase beginning at 6:00
AM) and relative humidity of 65%. Litters were standardized to have
six pups. The experimental procedures were approved by the Ethics
Committee for Animal Research from the Universidade Federal de
Pernambuco, which complies with the recommendations from the
National Institute of Health (Baltimore, USA).
2.2. Maternal diets
Both the standard and the experimental diets were formulated
based on recommendations of the American Institute of Nutrition
(AIN-93G) [28], and manufactured by the company Rhoster (São
Paulo/Brazil), being stored under refrigeration. The diets contained 7%
fat from goat milk (experimental diet), or from soybean oil (standard
diet), as the only fat source. Analysis of the fatty acid composition of
each diet revealed differences in the saturated-to-polyunsaturated
fatty acids ratio (Table 1). Moreover, the experimental diet contained1.2% of CLA, whereas in the standard diet no CLA was detected. There-
fore, both diets differed in lipid quality, but not in quantity.
One control- and three experimental groups were studied. The
control group (C) received the standard diet. The three experimen-
tal groups received the experimental diet at three different periods:
(1) during the gestation (group G); (2) during lactation (group L);
(3) during gestation plus lactation (group G+L). After weaning all
pups were kept on the control diet until the day of the CSD recording
session.
2.3. Recording of cortical spreading depression
At 35–45 days of life, under anesthesia (1 g/kg urethane plus
40 mg/kg chloralose, i.p.), two trephine holes (3 mm in diameter)
were drilled on the right parietal bone. The cortical spontaneous elec-
trical activity (Electrocorticogram) and the slow potential change
accompanying CSD were recorded simultaneously in these two points
on the cortical surface during 4 h by using a pair of Ag–AgCl agar-
Ringer electrodes. These electrodes consisted of 5-cm long plastic
conic pipettes (0.5 mm tip inner diameter), ﬁlled with Ringer solu-
tion, solidiﬁed with the addition of 0.5% agar, into which a chlorided
silver wire was inserted. The pipettes were pair-wise ﬁxed together
with cyanoacrylate glue, so that the inter-electrode distance was
kept constant for each pair of electrodes. A common reference elec-
trode, of the same type, was placed on the nasal bones. Spreading
depression was elicited at 20‐min intervals, through a third hole
(2 mm in diameter) drilled on the right frontal bone by applying,
for 1 min, a small cotton pledget (1–2 mm in diameter) soaked with
2% KCl solution (approximately 270 mmol/L). The three holes were
aligned in the anterior–posterior direction and parallel to the midline.
The CSDpropagation velocitywas calculated based on the time required
for a CSD wave to cross the distance between the two recording elec-
trodes. The incidence of “multiple” CSD, i.e., two or more CSD episodes
appearing after a single KCl stimulation, was also quantiﬁed. During
the recording session, the rectal temperature was maintained at 37±
1 °C by means of a heating blanket.
2.4. Physical parameters
After the recording session, the still anesthetized animal was sub-
mitted to the analysis of the following physical parameters, as
described by Novelli et al. [29]: body mass index (BMI; deﬁned as
weight [g]/ length2 [cm2]), thoracic circumference (TC) [cm],
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anesthetized animal was killed by inserting a ﬁne needle through the
cisterna magna, provoking bulbar lesion with cardio-respiratory arrest.
The brain was then removed and weighed.2.5. Measurement of brain fatty acids
For identiﬁcation and quantiﬁcation of fatty acids in the total
brain, the lipids from brain homogenates were separated, trans-
methylated and extracted in isooctane. The methyl fatty acids were
analyzed by a gas chromatography apparatus with a fused silica cap-
illary column of 100 m (SP 2500) with hydrogen as carrier gas
(1.8 mL/min) and a ﬂame ionization detector. Each sample was rotat-
ed to a temperature gradient from 70 to 240 °C to determine the peak
identiﬁcation of fatty acids.2.6. Statistical analysis
Intergroup differences in weights, physical parameters and CSD
velocity of propagation were analyzed by means of analysis of vari-
ance (ANOVA) followed by a post-hoc test (Tukey), when indicated.
The incidence of “multiple” CSDs was analyzed by the Kruskall–Wallis
ANOVA on ranks. Differences were considered signiﬁcant when
P≤0.05.3. Results
3.1. Body and brain weights and physical parameters
As shown in Fig. 1, the mean±sd body weights were higher in
the groups G, L and G+L, as compared to the control group, and
the differences were signiﬁcant (Pb0.05) at postnatal days 14, 21
and 28 (in this late age, only in groups L and G+L). The mean
values (in g) for the control, G, L and G+L groups were respective-
ly 27.55±2.07, 31.89±1.78, 31.38±3.27 and 33.26±4 on day 14;
39.53±2.45, 51.19±3.47, 50.60±4.57 and 51.79±8.60 on day
21; 69.51±4.87, 78.90±5.47, 80.63±7.79, and 82.46±13.24 on
day 28; and 117.32±7.68, 121.79±10.95, 119.17±14.67 and
125.02±16.49 on day 35.
No intergroup statistical difference was found regarding the
body length, abdominal circumference (AC), thoracic circumfer-
ence (TC), body mass index (IMC), abdominal to thoracic circumfer-
ence ratio (AC/TC) as well as brain weight measured on the day of
the CSD recordings. The mean values for these physical parameters
are shown in Table 2.Fig. 1. Body weights (mean±S.E.M.) of rats, evaluated at 7, 14, 21, 28 and 35 days of
life. C, G, L and G+L are groups from progenies of dams that received respectively
the control diet (C), or the CLA-diet during the gestation period (G), or during the lac-
tation period (L), or during both gestation+lactation (G+L). The number of animals
in each group is 10. The asterisks indicate values from the experimental groups that
are signiﬁcantly higher than the corresponding control values (Pb0.05; ANOVA plus
Tukey test).3.2. CSD elicitation and propagation
As a rule, the 1-min topical application of 270 mmol/L KCl on the
frontal cortex elicited a single CSD wave, which propagated and was
recorded by the two electrodes located more posterior in the stimu-
lated hemisphere. The ECoG depression and the slow potential
recordings conﬁrming the presence of CSD after KCl stimulation on
the cortical surface of four rats (one from each of the four groups)
are presented in Fig. 2.
The L and the G+L groups displayed higher CSD velocities of
propagation (Pb0.05), as compared to the C and G groups (in the
case of L group), and as compared to the C, G and L groups (in the
case of the G+L group). The means±sd velocities of propagation
(in mm/min) in the four groups were: group C, 3.45±0.19; group
G, 3.38±0.20; group L, 3.78±0.21; and group G+L, 4.37±0.35.
Data are illustrated in Fig. 3.
The fact that in the rat a single KCl stimulus elicits a single CSD
episode is a usual observation. In contrast to that, in some occasions
in the present experiments “multiple” CSD episodes appeared after
a single KCl stimulation. These “multiple” CSDs are considered as
evidence of a high brain susceptibility to the CSD phenomenon [30].
In the present study this was seen in 8 out of 14 C rats, 9 out of 13 G
rats, 8 out of 13 L rats and 9 out of 12 G+L rats. Fig. 4 presents the
number of “multiple” CSD expressed as medians and the 25%–75%
intervals. The Kruskall–Wallis one way ANOVA on ranks indicated
that the groups G and G+L displayed a signiﬁcantly (Pb0.05) higher
number of multiple episodes of CSD (medians: 7 and 7.5 CSD-
episodes, respectively) than the control and L groups, which presented
comparable values (median equals to 3 in both groups).
3.3. Brain fatty acids measurements
Table 3 presents the levels of several fatty acids measured in brain
homogenates of the 4 groups. One can see that the CLA molecules
C18:2c9t11 and C18:2t10c12 were present in the three experimental
groups, but not in the control rats.
4. Discussion
The main outcomes from this study were increased body weight
and faster CSD propagation in the developing rats born from
(group G), and/or suckled by dams fed the CLA-rich diet (groups L
and G+L). In this experimental diet only the quality of the dietary
lipid source was modiﬁed (fat from the goat milk, which is rich in
CLA), as compared to the control diet (soybean oil). Regarding the
effects of CLA on bodyweight, some reports from others have described
weight loss in obese humans [31] and in suckling rats [32,33] treated
with CLA. On the other hand, rats receiving a diet containing goat milk
did not present changes in body weight [34], and pups from dams
that received a CLA-supplemented diet during gestation and lactation
displayed increases in body weight [35]. The discrepancy between our
results and those from othersmay be due tomethodological differences
such as distinct CLA concentrations and sources (synthetic [31,32] ver-
sus goat milk in the present work), ages (adults [34] versus sucklings),
and the health status of the organism (obese [31] versus eutrophic). The
body weight loss in the CLA-treated groups has been attributed to a
decrease of triglycerides in the lactating milk [32], or to a reduction in
the synthesis of fatty acids by CLA action on lipogenic enzymes [33].
In our experiment, we used only the lipids from goat milk and CLA
was present in this lipid source. The fat from goat milk contains several
lipids including saturated, monounsaturated and polyunsaturated fatty
acids. This possibly contributed to the increase in body weight of pups
compared with the control group, which received a diet containing
predominantly polyunsaturated fatty acids.
Because the measurement of physical parameters other than body
weight required anesthesia, such measurement was performed only
Table 2
Physical parameters of 35–45 day old male rats, whose dams received the control diet
containing soybean oil as the only fat source (control group) or the experimental diet
containing fat from goat milk (which contains conjugated fatty acids), either during
gestation, or lactation, or both gestation plus lactation periods. Data are expressed as
mean±sd. The number of animals in each group is 10. No intergroup signiﬁcant differ-
ences could be detected.
Physical parameters Groups
Control Gestation Lactation Gest+
Lact.
Body length (cm) 18.3±0.9 17.4±1.0 18.4±0.6 18.4±1.3
Abdominal circumference (AC; cm) 13.1±1.3 12.4±0.9 13.0±0.5 13.5±1.1
Thoracic circumference (TC; cm) 11.1±1.2 10.8±0.6 11.4±0.5 11.7±0.6
AC/TC ratio 1.18±0.1 1.14±0.1 1.16±0.1 1.15±0.1
Body mass index (g/cm2) 0.49±0.1 0.50±0.1 0.47±0.1 0.48±0.1
Tail length (cm) 13.5±1.2 13.2±0.9 13.5±1.4 14.3±1.0
Brain weight (g) 1.63±0.1 1.71±0.1 1.67±0.1 1.61±0.1
Fig. 3. Velocities of propagation of CSD in 35–45 day-old rats whose dams received the
control diet (C), or the CLA-diet during the gestation (G), lactation (L) or both periods
(G+L). The number of animals in the groups C, G, L and G+L is 14, 13, 13 and 12,
respectively. Data are expressed as mean±S.E.M. of twelve CSD episodes elicited, at 20-
min intervals, by 1-minKCl application during the 4 h recording period. The groupmarked
with one asterisk differs from the groups C and G. The groupmarkedwith (#) differs from
all other three groups (ANOVA plus Tukey-test; Pb0.05).
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body weights, nor the other physical parameters in the CLA-treated
animals presented any changes, as compared to the control group,
suggesting that the CLA effects on body development were short-
lasting. Notwithstanding the absence of weight difference, a signiﬁ-
cant CLA-associated enhancement in CSD propagation could still be
demonstrated, suggesting a long lasting brain electrophysiological
effect. This indicates a differential effect of CLA in the maternal diet
regarding growth of the pups (short term effect) and CSD propaga-
tion (long term effect).
Regarding CSD, the increase in its speed of propagation was more
evident when the maternal CLA-treatment occurred during lactation,
as compared to the gestation period, and this effect was potentiated
when the dams were treated during gestation plus lactation. Data
raise the questions on why the lactation period is more vulnerable
than the gestation period and how the CLA would be involved inFig. 2. Electrocorticogram (E) and slow potential change (P) recorded during cortical
spreading depression (CSD), in four 35–45 day-old rats from the group control (C),
and from the groups whose dams received the CLA-diet during gestation (G), or lacta-
tion (L), or both gestation+lactation (G+L). The horizontal bars in P1 show the peri-
od (1 min) of stimulation with 2% KCl, necessary to elicit CSD. The vertical bars equal
−10 and −1 mV, respectively for the P and E recordings (negativity is upwards).
The places of KCl application and of the reference electrode are indicated in the inset,
which also shows the recording points 1 and 2 (from which the traces marked at the
left with the same numbers were recorded). Note that in animals of the groups G
and G+L a single KCl stimulation elicited two or more CSD episodes.such developmental and electrophysiological effects. One possibility
is that CLA would impair brain myelination, a developmental process
that in mammals attains maximal intensity during the lactation
[36]. Modiﬁcations in dietary lipids have been associated in the rat
to changes in myelination mediators as mRNA, proteolipid protein
and oligodendrocyte glycoprotein [37], and also to myelination-
dependent auditory response conduction [38,39]. Interestingly, accel-
erated and decelerated CSD propagations have been associated with
cortical demyelination and hypermyelination, respectively [40]. The
facilitated CSD propagation shown in the present work stands in con-
trast with the CSD deceleration previously observed in rats treated
during pregnancy and lactation with a diet rich in saturated fatty
acids, which increases myelination [19]. In view of this evidence, we
are tempted to suggest that the CLA-rich maternal diet used in this
work probably impaired myelin synthesis in the progeny, and this
would be causally involved in the CSD acceleration, as presently
observed. In addition the increased incidence of “multiple” CSD epi-
sodes, after a single KCl stimulation, has been observed in the progenies
from dams treated with CLA during the gestation period (groups G and
G+L), rather than during lactation. This suggests that CLA acting on the
two different developmental time points (gestation and lactation) af-
fects distinct processes leading to the two CSD alterations, respectively
increased incidence of multiple CSD, and higher CSD propagation veloc-
ities. Further speciﬁc experiments shall clarify this point.
Regarding the relationship between CSD and human neurological
disorders, CSD has been postulated as representing an important
pathophysiological hallmark for human migraine, and it has also
been associated with epilepsy [27]. Interestingly, an increased preva-
lence of epilepsy is noted in patients with multiple sclerosis [41], a
demyelinating disease [42], as compared to the general population.
All the evidence notwithstanding, we believe that future experiments
in which brain myelin will be quantiﬁed are required to deﬁnitely
conﬁrm our hypothesis.
Another possibility that could explain the effect of the CLA-rich
diet in increasing CSD velocity would be based on the imbalance of
the n−6:n−3 ratio in the brain of the CLA-treated rats. This possibility
has been recently discussed by Borba et al. [19] in rats under dietary
essential fatty acid (EFA) deﬁciency over two generations, based on
the speculation that the n−6:n−3 imbalance could change cortical
excitability by activating K+ channels in neurons and by attenuating
the oscillations in astrocytic Ca2+ concentration [43,44]. This excitabil-
ity hypothesis raises the possibility that the ﬁnely balanced interactions
between astrocytes and neurons could contribute for the facilitating
effects induced by the CLA-rich diet upon CSD. In fact, it is known
from the literature that disruption of the glia–neuron interaction in-
duced by ﬂuorocitrate can also facilitate CSD in the rat hippocampus
Fig. 4. Number of cases in which a single KCl stimulation for 1 min elicited multiple epi-
sodes of cortical spreading depression (CSD), in the four nutritional groups. C, G, L and
G+L are groups composed from progenies of dams that received respectively the control
diet (C), or the CLA-diet during the gestation period (G), or the lactation period (L), or both
gestation+lactation (G+L). Multiple CSD episodes were presently observed in 8 out of
14 C rats, 9 out of 13 G rats, 8 out of 13 L rats and 9 out of 12 G+L rats. Data are expressed
as medians, with the 25%–75% intervals. The groups marked with an asterisk are signiﬁ-
cantly different from the asterisk-free groups (Pb0.05; Kruskall–Wallis followed by
Dunn's test).
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trol diet, our CLA-rich diet was deﬁcient in both n−3 and n−6 fatty
acids (proportionately more deﬁcient in n−6 than in n−3 fatty
acids), and this resulted in a 50% decrease of the n−6:n−3 ratio
(from 22.52 in the control diet to 11.38 in the CLA-diet). The n−6:
n−3 ratio is considered as an important nutritional factor for ade-
quate brain development [2,6], and maternal diets containing differ-
ent n−6:n−3 ratios have been associated with modiﬁcations in the
time course of reﬂex ontogeny and in physical parameters in the rat
progeny [4]. PUFA also may protect the brain from damage by induc-
ing robust dilatation of the cerebral vessels [46]. More recently,
Blondeau et al. [47] observed that linolenic- and docosahexanoic
acid induced vasodilation of the basilar artery, and this could affect
TREK-1 potassium channel. Because CSD is associated with increase
in cerebral blood ﬂow, besides modiﬁcations in extracellular levels
of ions and neurotransmitters [48] one cannot discard the possibility
that the linoleic acid content in the lipids from goat milk, used in the
present study, in conjunction with other factors may facilitate the
propagation of CSD as presently found.Table 3
Brain fatty acids (as percent of total fatty acids) in 35–45 day old male rats, whose dams
received the control diet containing soybean oil as the only fat source (group C), or the
experimental diet containing fat from goat milk (which contains conjugated fatty acids),
either during gestation, or lactation, or both gestation plus lactation periods (respectively
groups G, L and G+L). Data are expressed as mean±sd, and the number of animals in
each group is 10. Two conjugated fatty acids, C18:2cis9-trans11 and C18:2trans10-cis12,
are present in the brains of the experimental group, but not in the control rats. Asterisks
indicate values that are signiﬁcantly different from the corresponding control values.
Brain fatty acids Groups
C G L G+L
C16:1 28.37±2.32 34.81±4.05 27.89±5.18 33.12±7.1
C17:0 0.32±0.04 0.40±0.13 0.35±0.09 0.35±0.13
C18:0 0.29±0.03 0.37±0.07 0.39±0.02 0.41±0.03
C18:1n9t 25.04±3.25 25.69±3.12 23.81±1.74 25.19±3.79
C18:1n9c 1.19±0.91 1.18±0.65 1.35±0.47 2.14±2.69
C18:2n6c 19.02±2.65 18.16±3.87 18.57±0.74 16.37±1.15
C18:3n6 0.75±0.08 0.91±0.12 0.65±0.15 0.68±0.11
C18:2c9t11-CLA 0.00 0.75±0.08* 1.38±0.42* 1.85±0.85*
C18:2t10c12-CLA 0.00 0.53±0.06 0.60±0.20* 1.25±0.08*
C18:3n3 1.28±0.42 0.96±0.23 1.32±0.29 1.06±0.47
C20:4 8.58±0.88 6.92±1.89 8.01±1.70 7.28±1.66
C22:4 2.75±0.37 1.54±0.66 2.57±0.78 1.98±0.86
C22:6 7.87±2.55 4.63±2.87 8.93±3.07 5.45±1.59
ND 4.26 2.96 3.81 2.60The idea that fatty acids would protect the neurons against
glutamate-induced excitotoxicity is supported by evidence from in
vivo experiments. Suckling rats whose dams were treated with die-
tary supplementation of ﬁsh oil, which is rich in Long Chain-PUFAs,
displayed a reduction of NMDA-induced excitotoxic degeneration of
cholinergic neurons [49]. Recently, a protective effect of CLA against
glutamate excitotoxic action has been demonstrated in neuron
cultures from mouse brain [17]. Considering that CSD is inﬂuenced by
brain excitability changes [50,51], it is tempting to hypothesize that at
least some of the CLA effects on CSD would involve CLA-dependent
excitability alterations. Additional speciﬁc studies are needed to con-
ﬁrm this hypothesis.
In conclusion, our data documented, for the ﬁrst time, a differential,
facilitating effect of the lipids from goat milk on (1) body growth
(a short-lasting effect), and on (2) an excitability-related phenomenon
in the brain (CSD; long-lasting effect) that has causally been associated
to important neurological disturbances like migraine and epilepsy. The
data advance the understanding of the mechanisms by which dietary
lipids can inﬂuence brain development and electrophysiological prop-
erties. Therefore, results may shed light on the comprehension of
lipid-associated processes that may be involved in excitability-related
neurological diseases.Acknowledgements
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